PIK3CA and non-small cell lung carcinoma: This study not only aims to elucidate the molecular mechanisms underlying the interaction between PI3K mutations and the immune microenvironment but also provides novel insights and approaches for the targeted therapy of NSCLC, holding significant scientific and clinical implications.